Physician profile
Andrew D Brown
NPI 1104209220
$4,317.29
in general payments reported to CMS, 2019-2025
18 companies · $759 in 2025
The $759 reported for 2025 was more than what 86% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $567 · 2020: $578 · 2021: $700 · 2022: $373 · 2023: $490 · 2024: $849 · 2025: $759.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,088 · Education: $10.30.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,088.40 |
| Education | $10.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $1,042.53 | 2019-2022 | |
| Oyster Point Pharma, INC. | $458.89 | 2022-2025 | Tyrvaya |
| Bausch & Lomb Americas INC. | $440.73 | 2022-2025 | Infuse, Xiidra, Miebo |
| Sun Pharmaceutical Industries INC. | $361.25 | 2019-2025 | Cequa, Xelpros |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $345.58 | 2019-2021 | |
| Abbvie INC. | $324.68 | 2022-2025 | Durysta |
| Tarsus Pharmaceuticals, INC. | $277.25 | 2024-2025 | Xdemvy |
| Alcon Vision LLC | $208.51 | 2020-2025 | Total30, Eysuvis, Precision 1 |
| Mallinckrodt Hospital Products INC. | $182.28 | 2023-2024 | Acthar |
| Novartis Pharmaceuticals Corporation | $181.34 | 2019-2022 | |
| Johnson & Johnson Surgical Vision, INC. | $125.02 | 2025 | Tecnis Iol |
| Dompe US, INC. | $105.15 | 2025 | Oxervate |
| Kala Pharmaceuticals, INC. | $95.42 | 2021 | |
| Astellas Pharma US INC | $50.18 | 2024 | Izervay |
| Coopervision INC. | $49.08 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Elite Orthopedics, LLC | $30.14 | 2020 | |
| Thea Pharma INC. | $26.28 | 2023 | |
| Glaukos Corporation | $12.98 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.